The only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...
Read moreOverall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...
Read moreThe objective of this research was to understand the processes and outputs from different European p...
Read moreMedicare would use a new International Pricing Index (IPI) model that considers international refere...
Read morePfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire ...
Read moreSetting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...
Read moreOrphan drugs have important societal value as they improve patient quality of life and address unmet...
Read moreNHS England’s cost-effectiveness watchdog, (NICE), issued a first draft document saying that it di...
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...
Read moreSince 29th July 2016 the NICE appraisal process for oncology indications in England has been modifie...
Read more